Abstract - BEYOND PSA - PROSTATE CANCER BIOMARKERS IN PROSTATE CANCER DIAGNOSIS
Lincoln Tan Guan Lim, MBBS (Singapore), MMed (Surgery), FRCS (Urol)(RCPSG)
National University Hospital Singapore
PSA is a deeply flawed tumour marker that is responsible for much misery. New biomarkers with improved performance that are commercially available will be reviewed.